160 related articles for article (PubMed ID: 28322086)
1. Viability of SH-SY5Y cells is associated with purinergic P2 receptor expression alterations.
Örçen A; Yilmaz V; Giriş M; Akcan U; Tüzün E; Erten G
Acta Biol Hung; 2017 Mar; 68(1):22-34. PubMed ID: 28322086
[TBL] [Abstract][Full Text] [Related]
2. P19 embryonal carcinoma cells as in vitro model for studying purinergic receptor expression and modulation of N-methyl-D-aspartate-glutamate and acetylcholine receptors during neuronal differentiation.
Resende RR; Majumder P; Gomes KN; Britto LR; Ulrich H
Neuroscience; 2007 May; 146(3):1169-81. PubMed ID: 17418494
[TBL] [Abstract][Full Text] [Related]
3. Cloned and transfected P2Y4 receptors: characterization of a suramin and PPADS-insensitive response to UTP.
Charlton SJ; Brown CA; Weisman GA; Turner JT; Erb L; Boarder MR
Br J Pharmacol; 1996 Dec; 119(7):1301-3. PubMed ID: 8968535
[TBL] [Abstract][Full Text] [Related]
4. The metabotropic P2Y4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells.
Cavaliere F; Nestola V; Amadio S; D'Ambrosi N; Angelini DF; Sancesario G; Bernardi G; Volonté C
Neurobiol Dis; 2005 Feb; 18(1):100-9. PubMed ID: 15649700
[TBL] [Abstract][Full Text] [Related]
5. Evidence for P2Y1, P2Y2, P2Y6 and atypical UTP-sensitive receptors coupled to rises in intracellular calcium in mouse cultured superior cervical ganglion neurons and glia.
Calvert JA; Atterbury-Thomas AE; Leon C; Forsythe ID; Gachet C; Evans RJ
Br J Pharmacol; 2004 Nov; 143(5):525-32. PubMed ID: 15466449
[TBL] [Abstract][Full Text] [Related]
6. Evidence for the expression of multiple uracil nucleotide-stimulated P2 receptors coupled to smooth muscle contraction in porcine isolated arteries.
Rayment SJ; Latif ML; Ralevic V; Alexander SP
Br J Pharmacol; 2007 Mar; 150(5):604-12. PubMed ID: 17262017
[TBL] [Abstract][Full Text] [Related]
7. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
[TBL] [Abstract][Full Text] [Related]
8. Extracellular ATP has stimulatory effects on the expression and release of IL-6 via purinergic receptors in normal human epidermal keratinocytes.
Inoue K; Hosoi J; Denda M
J Invest Dermatol; 2007 Feb; 127(2):362-71. PubMed ID: 16946718
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of the response to purinergic agonists in P2Y1 transfected 1321N1 cells by antagonists suramin and PPADS.
Brown CA; Charlton SJ; Boarder MR
Br J Pharmacol; 1997 Mar; 120(6):1049-52. PubMed ID: 9134216
[TBL] [Abstract][Full Text] [Related]
10. Purinergic receptor P2Y6 contributes to 1-methyl-4-phenylpyridinium-induced oxidative stress and cell death in neuronal SH-SY5Y cells.
Qian Y; Xu S; Yang X; Xiao Q
J Neurosci Res; 2018 Feb; 96(2):253-264. PubMed ID: 28752899
[TBL] [Abstract][Full Text] [Related]
11. Hypotonic stress activates BK channels in clonal kidney cells via purinergic receptors, presumably of the P2Y subtype.
Hafting T; Haug TM; Ellefsen S; Sand O
Acta Physiol (Oxf); 2006 Sep; 188(1):21-31. PubMed ID: 16911250
[TBL] [Abstract][Full Text] [Related]
12. Comparison of P2 receptor subtypes producing dilation in rat intracerebral arterioles.
Horiuchi T; Dietrich HH; Hongo K; Dacey RG
Stroke; 2003 Jun; 34(6):1473-8. PubMed ID: 12730558
[TBL] [Abstract][Full Text] [Related]
13. Functional evidence that ATP or a related purine is an inhibitory NANC neurotransmitter in the mouse jejunum: study on the identity of P2X and P2Y purinoceptors involved.
De Man JG; De Winter BY; Seerden TC; De Schepper HU; Herman AG; Pelckmans PA
Br J Pharmacol; 2003 Nov; 140(6):1108-16. PubMed ID: 14530212
[TBL] [Abstract][Full Text] [Related]
14. Evidence that rat hepatocytes co-express functional P2Y1 and P2Y2 receptors.
Dixon CJ; Woods NM; Webb TE; Green AK
Br J Pharmacol; 2000 Feb; 129(4):764-70. PubMed ID: 10683201
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of nucleotide P2Y receptors on endothelial cells of the mouse aorta.
Guns PJ; Korda A; Crauwels HM; Van Assche T; Robaye B; Boeynaems JM; Bult H
Br J Pharmacol; 2005 Sep; 146(2):288-95. PubMed ID: 15997227
[TBL] [Abstract][Full Text] [Related]
16. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
Washburn KB; Neary JT
Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
[TBL] [Abstract][Full Text] [Related]
17. Involvement of purinergic P2 receptors in experimental retinal neovascularization.
Sarman S; Mancini J; van der Ploeg I; Croxatto JO; Kvanta A; Gallo JE
Curr Eye Res; 2008 Mar; 33(3):285-91. PubMed ID: 18350440
[TBL] [Abstract][Full Text] [Related]
18. Functional expression of ionotropic purinergic receptors on mouse taste bud cells.
Hayato R; Ohtubo Y; Yoshii K
J Physiol; 2007 Oct; 584(Pt 2):473-88. PubMed ID: 17702819
[TBL] [Abstract][Full Text] [Related]
19. Enhanced P2Y1 receptor expression in the brain after sensitisation with d-amphetamine.
Franke H; Kittner H; Grosche J; Illes P
Psychopharmacology (Berl); 2003 May; 167(2):187-94. PubMed ID: 12652343
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and characterization of the mouse P2Y4 nucleotide receptor.
Suarez-Huerta N; Pouillon V; Boeynaems J; Robaye B
Eur J Pharmacol; 2001 Mar; 416(3):197-202. PubMed ID: 11290369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
